Jan M Moll
2PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (2)
Sort by Publication Date:
|Jan 17, 2022
Abiraterone switches castration-resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling.J Matthijs Moll, Johannes Hofland, Wilma J Teubel
|Apr 25, 2019
A bypass mechanism of abiraterone-resistant prostate cancer: Accumulating CYP17A1 substrates activate androgen receptor signaling.Jan M Moll, Jinpei Kumagai, Martin E van Royen
Pageof 1
